Metabolic dysfunction in obesity is related to impaired suppression of fatty acid release from adipose tissue by insulin. 2023

Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
Substrate Metabolism Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, Michigan, USA.

The aims of this study were: 1) to assess relationships among insulin-mediated glucose uptake with standard clinical outcomes and deep-phenotyping measures (including fatty acid [FA] rate of appearance [FA Ra] into the systemic circulation); and 2) to examine the contribution of adipocyte size, fibrosis, and proteomic profile to FA Ra regulation. A total of 66 adults with obesity (BMI = 34 [SD 3] kg/m2 ) were assessed for insulin sensitivity (hyperinsulinemic-euglycemic clamp), and stable isotope dilution methods quantified glucose, FA, and glycerol kinetics in vivo. Abdominal subcutaneous adipose tissue (aSAT) and skeletal muscle biopsies were collected, and magnetic resonance imaging quantified liver and visceral fat content. Insulin-mediated FA Ra suppression associated with insulin-mediated glucose uptake (r = 0.51; p < 0.01) and negatively correlated with liver (r = -0.36; p < 0.01) and visceral fat (r = -0.42; p < 0.01). aSAT proteomics from subcohorts of participants with low FA Ra suppression (n = 8) versus high FA Ra suppression (n = 8) demonstrated greater extracellular matrix collagen protein in low versus high FA Ra suppression. Skeletal muscle lipidomics (n = 18) revealed inverse correlations of FA Ra suppression with acyl-chain length of acylcarnitine (r = -0.42; p = 0.02) and triacylglycerol (r = -0.51; p < 0.01), in addition to insulin-mediated glucose uptake (acylcarnitine: r = -0.49; p < 0.01, triacylglycerol: r = -0.40; p < 0.01). Insulin's ability to suppress FA release from aSAT in obesity is related to enhanced insulin-mediated glucose uptake and metabolic health in peripheral tissues.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D015309 Glucose Clamp Technique Maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. It is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration. Euglycemic Clamping,Glucose Clamping,Euglycaemic Clamp,Euglycaemic Clamping,Euglycemic Clamp,Glucose Clamp,Glucose Clamp Technic,Clamp, Euglycaemic,Clamp, Euglycemic,Clamp, Glucose,Clamping, Euglycaemic,Clamping, Euglycemic,Clamping, Glucose,Clamps, Euglycaemic,Clamps, Euglycemic,Clamps, Glucose,Euglycaemic Clamps,Euglycemic Clamps,Glucose Clamp Technics,Glucose Clamp Techniques,Glucose Clamps,Technic, Glucose Clamp,Technics, Glucose Clamp,Technique, Glucose Clamp,Techniques, Glucose Clamp

Related Publications

Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
April 2013, Best practice & research. Clinical endocrinology & metabolism,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
June 2008, Minerva medica,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
February 1979, Endokrinologie,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
July 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
September 1967, The Journal of laboratory and clinical medicine,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
September 1977, Ceskoslovenska gastroenterologie a vyziva,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
January 2022, Handbook of experimental pharmacology,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
September 2020, Scientific reports,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
January 2015, Frontiers in endocrinology,
Michael W Schleh, and Benjamin J Ryan, and Cheehoon Ahn, and Alison C Ludzki, and Pallavi Varshney, and Jenna B Gillen, and Douglas W Van Pelt, and Lisa M Pitchford, and Suzette M Howton, and Thomas Rode, and Thomas L Chenevert, and Scott L Hummel, and Charles F Burant, and Jeffrey F Horowitz
March 2021, American journal of physiology. Cell physiology,
Copied contents to your clipboard!